ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Biotechnology

U.S. biotech unicorn eyes bigger China presence from Singapore

10x Genomics opens Asia headquarters in city-state, supporting COVID-19 research

10x Genomics' Asia-Pacific headquarters in Singapore includes the company's first manufacturing facility outside the U.S. (Photo courtesy of 10x Genomics)

SINGAPORE -- U.S. biotechnology unicorn 10x Genomics opened its Asia-Pacific headquarters and first overseas manufacturing facility in Singapore on Monday as the company aims to expand its presence in China and other regional markets.

The Nasdaq-listed company, which has a market capitalization of over $15 billion, designs and makes gene sequencing technology for scientific research, including products that have been used to support work in treating COVID-19. 10x sells both the machines and the software needed for analyzing biological systems.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more